Episode 30 – SGLT2 inhibitors and GLP-1 agonists in Diabetes (Repeat)

Welcome back Rounds Table Listeners!

We are back today with an oldie but a goodie!

In this repeat episode, Mike and John do a Rapid Fire session to discuss two recent papers exploring the cardiovascular and renal benefits of two medications used in the management of diabetes. Two papers, here we go! 

  1. Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF (0:00 – 6:58).
  2. Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes (6:58 – 13:35).

And for the Good Stuff: 

Questions? Comments? Feedback? We’d love to hear from you! @roundstable

Leave a Comment

Your email address will not be published. Required fields are marked *

Republish this article

Republish this article on your website under the creative commons licence.

Learn more